openPR Logo
Press release

The Global Heparin market is expected to grow at a CAGR of 6.4% as the world moves towards better technology to prevent blood clotting

06-20-2019 11:29 AM CET | Health & Medicine

Press release from: DataM Intelligence

The Global Heparin market is expected to grow at a CAGR of 6.4% as

Hyderabad, June 20, 2019 -- The "Heparin Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.

With approximately 500 million doses of heparin being used worldwide every year, the annual market for Heparin was valued at USD 10 billion in 2017.

Click here to get your copy of free sample https://www.datamintelligence.com/research-report/heparin-market

Heparin Market Trends : Drivers and Restraints
The market has significant growth opportunities owing to growing potential applications of heparin ranging from anti-inflammatory and anti-tumor applications to prevention of infectious disease and use as nano-carriers for drug delivery.
Also, the rising number of coagulation disorders such as venous thromboembolism (VTE) will also fuel market growth.
However, the wide availability of alternative anticoagulants such as warfarin, coumarins, and oral anticoagulants are expected to hamper heparin sales, thereby negatively impacting market growth.

Heparin Market Segmentation:
By Product Type
⦁Unfractioned Heparin (UFH)
⦁Low Molecular Weight Heparin (LMWH)
⦁Ultra-Low Molecular Weight Heparin (ULMWH)
By Source Type
⦁Bovine
⦁Porcine
By Formulation Type
⦁Oral
⦁Parenteral
By Region
⦁Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
⦁Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
⦁North America (The USA, Canada, Mexico)
⦁South America (Brazil, Argentina, Rest of South America)
⦁Rest of the World

Key Points covered in the report
⦁Heparin Market – Methodology and Scope
⦁Heparin Market - Trends
⦁Heparin Market – Industry Analysis
⦁Geographical Analysis
⦁Competitive Landscape
⦁Company Profiles

Heparin Market Key Companies
Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc., B. Braun Melsungen AG, and Syntex S.A.
For more information about this report visit https://www.datamintelligence.com/research-report/heparin-market

DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research.

About DataM Intelligence :
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historic data but also allows a highly justifiable forecast model.
DMI is currently strengthening its cross-industrial database for sectors including Chemicals, Materials, Agriculture, Healthcare Services, Animal Nutrition, Consumer Goods, Food & Beverages, Industrial Machinery and Automation among others.

1st floor, Phoenix Tech Tower, Plo no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Heparin market is expected to grow at a CAGR of 6.4% as the world moves towards better technology to prevent blood clotting here

News-ID: 1782351 • Views:

More Releases from DataM Intelligence

U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6.3% CAGR Driven by Advances in Nuclear Medicine and Theranostics
U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6 …
The United States radiopharmaceuticals market was valued at USD 2.21 billion in 2024 and is projected to reach USD 2.36 billion by 2033, exhibiting a CAGR of 6.3% during the forecast period, according to DataM Intelligence. The market expansion is primarily fueled by the growing prevalence of chronic diseases such as cancer and cardiovascular disorders, advancements in diagnostic imaging, and regulatory support for nuclear medicine infrastructure. Radiopharmaceuticals play a pivotal
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR Driven by Demand for Natural and Innovative Taste Solutions
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR …
The U.S. flavors market was valued at USD 3,887.7 million in 2024 and is projected to reach USD 6,108.4 million by 2033, growing at a CAGR of 5.2% during 2025-2033, according to DataM Intelligence. The market's growth is driven by surging demand for processed foods, global flavor innovation, and increasing consumer preference for natural, clean-label, and wellness-oriented products. Flavors continue to play a vital role in enhancing the sensory experience
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% CAGR Amid Rising Animal Nutrition Investments
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% …
The Europe Feed Premix Market is estimated to grow from USD 5.92 billion in 2025 to USD 7.31 billion by 2030, registering a CAGR of 4.32% during the forecast period, according to DataM Intelligence. The market's growth is driven by increasing demand for nutrient-rich animal feed formulations, expanding livestock production, and a rising preference for high-quality, antibiotic-free animal products. Feed premixes-comprising essential vitamins, minerals, amino acids, and other additives-are vital
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growing at a 5.5% CAGR on Rising Demand for Natural Additives
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growin …
The North America Feed Phytogenics Market is projected to grow from USD 383.10 million in 2025 to USD 500.60 million by 2030, at a CAGR of 5.5% during the forecast period, according to DataM Intelligence. The market is witnessing robust growth due to rising demand for high-quality animal-derived products and increasing regulatory restrictions on antibiotics in livestock production. As a result, plant-based feed solutions have gained widespread adoption for improving

All 5 Releases


More Releases for Heparin

Heparin (Heparin Sodium and Heparin Calcium) Market Size, Overview And Forecast …
"The Global Heparin (Heparin Sodium and Heparin Calcium) Market Size is projected to reach at a CAGR of 3.4% during 2024-2032." Global Heparin (Heparin Sodium and Heparin Calcium) market Size, Status, and Forecast for the 2024-2032. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Heparin (Heparin Sodium and Heparin Calcium) Market including
Heparin (Heparin Sodium and Heparin Calcium) Market explores demand trends, grow …
"𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬 𝐰𝐢𝐭𝐡 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐌𝐚𝐤𝐢𝐧𝐠" The global Heparin (Heparin Sodium and Heparin Calcium) market is anticipated to grow from USD 1,202 Million in 2023 to USD 1,509 Million by 2033, at a CAGR of 3.3 % during the forecast period. Heparin (Heparin Sodium and Heparin Calcium) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐜𝐨𝐩𝐞, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟑 𝐫𝐞𝐩𝐨𝐫𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝 𝐢𝐧 𝐄𝐱𝐚𝐜𝐭𝐢𝐭𝐮𝐝𝐞 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐜𝐲'𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧. Heparin (Heparin Sodium and Heparin Calcium) Market
Heparin Market Report 2023 | Increasing the Advantages of Low Molecular Weight H …
According to Precision Business Insights (PBI), the latest report the global heparin market size was valued at USD 7,923.7 million in 2022 and is projected to grow at a 2.8% CAGR during the forecast period 2023 to 2029. The efficacy of these drugs as an anticoagulant is one of the key factors expected to drive global market growth. Furthermore, undeniable factors such as technological advancement and introducing of new products
Heparin Market
The heparin market refers to the global market for heparin, a blood-thinning medication that is commonly used in the prevention and treatment of blood clots. Heparin is typically derived from the mucous membranes of animals such as pigs and cows, and it is commonly used in a variety of medical settings, including hospitals, clinics, and home care settings. The heparin market has experienced steady growth over the past few years, driven
Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Heparin Market: Rapid Growth of Heparin Market Anticipated in Several European N …
Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as